GEMITERO gemcitabine (as hydrochloride) 200 mg powder for injection vial

国家: 澳大利亚

语言: 英文

来源: Department of Health (Therapeutic Goods Administration)

有效成分:

gemcitabine hydrochloride, Quantity: 228 mg

可用日期:

Hetero Australia Pty Ltd

INN（国际名称）:

Gemcitabine hydrochloride

药物剂型:

Injection, powder for

组成:

Excipient Ingredients: mannitol; sodium hydroxide; sodium acetate trihydrate

给药途径:

Intravenous Infusion

每包单位数:

1 vial

处方类型:

(S4) Prescription Only Medicine

疗效迹象:

Gemcitabine is indicated for treatment of patients with locally advanced or metastatic non- small cell lung cancer.,Gemcitabine is indicated for treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas. Gemcitabine is also indicated for patients with 5-FU refractory pancreatic cancer.,Gemcitabine, alone or in combination with cisplatin, is indicated for treatment of patients with bladder cancer.,Gemcitabine, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated.,Gemcitabine, in combination with carboplatin, is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma, who have relapsed > 6 months following platinum? based therapy

產品總結:

Visual Identification: White to off-white lyophilised powder to be reconstituted for intravenous use.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

授权状态:

Licence status A

授权日期:

2015-03-03